Table 2

Metabolism of phosphoramidate triesters of d4TMP or AZTMP after overnight incubation with pig liver carboxylesterase, human serum, CEM cell extract, and mouse serum

NumberAmino Acid/EsterIntact Prodrug and Its Metabolism after Incubation with:2-a
CarboxylesteraseHuman SerumCEM ExtractMouse Serum
Intact ProdrugIMAAMIntact ProdrugIMAAMIntact ProdrugIMAAMIntact ProdrugIMAAM
%
d4TMP derivatives
 1 l-Alanine/Bz0010020080809200100
 2 l-Alanine/Me00100360622-b 140842-b 00982-b
 3 l-Alanine/Et00100760232-b 260722-b 00982-b
 4 Methyl-l-aspartic acid/Me001001808200992-b 00992-b
 5 d-Alanine/Me0010066034580429091
 6 Glycine/Me00100550454905100100
 7 l-Leucine/Me13087790215204820080
 8 l-Valine/Me10000100001000010000
 9 l-Methionine/Me11089400603306715085
 10 l-Phenylalanine/Me00100460543706318082
 11 Methyl-l-glutamic acid/Me0356538342825403502575
 12 β-Alanine/Et0100092807426001000
AZTMP derivatives
 13 Glycine/Me0010052048NDNDND00100
 14 l-Alanine/Me001004205880902-b 00982-b
 15 l-Leucine/Me07030533413246016776162-b
 16 d-Alanine/Me00100540452-b 540452-b 00982-b
 17 l-Phenylalanine/Me00100424018384319293140
 18 Methyl-l-glutamic acid/Me0514932452312394993754
  • 2-a The phosphoramidate derivatives of d4TMP or AZTMP were incubated overnight with carboxylesterase or with biological media, after which the remaining intact prodrug and the IM and AAM following metabolites were determined by HPLC.

  • 2-b Due to the minor formation of ddNMP + ddN (≤2%), the total of intact prodrug + IM + AAM was not 100%.

  • N.D., not determined.